Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,887.00
Bid: 1,886.00
Ask: 1,888.00
Change: -30.00 (-1.56%)
Spread: 2.00 (0.106%)
Open: 1,921.00
High: 1,921.00
Low: 1,887.00
Prev. Close: 1,917.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: FTSE 100 on track for fourth straight loss

Wed, 17th Apr 2013 11:39

A number of heavyweight stocks going ex-dividend assured that London's FTSE 100 index was in the red for a fourth consecutive day on Wednesday, while concerns over the global economy continued to weigh on sentiment.Global growth fears have hit markets over the last few days after a surprise slowdown was reported in China in the first quarter. These concerns were compounded yesterday when the International Monetary Fund (IMF) revised lower its forecasts for global economic growth, cutting estimates for the UK, US, Eurozone and China.Unconfirmed rumours of a German credit rating downgrade were also giving investors more reasons to be cautious this morning, as well as the UK unemployment rate rising from 7.8% to 7.9% in the three months to February.The minutes from the latest Bank of England's Monetary Policy Committee (MPC) meeting released today showed that policymakers were split six to three in favour of maintaining the asset purchase programme at £375bn, as expected. They voted unanimously to keep the Bank Rate at 0.5%.For Barclays Research, today's minutes confirm its view that the redrafted MPC remit included in the March Budget does not give the committee greater leeway to focus on stimulating the economy. In that same vein, analysts point out that should activity stabilise, afterwards returning to growth while inflation stays high, then a majority of the MPC will not vote to increase quantitative easing (QE). However, they said that "it would take relatively little bad news on demand to propel the committee into a further QE push".US indices performed well last night after Goldman Sachs joined a growing list of companies to report better-than-expected earnings. Banking peers Citigroup, Wells Fargo and JPMorgan Chase have all beaten forecasts with their first-quarter results in the past week. Futures Stateside are pointing to a weak start ahead of earnings from Bank of America ahead of the opening bell.FTSE 100: Ex-div stocks provide a dragA number of heavyweight constituents went ex-dividend this morning, meaning that new investors will not be able to get their hands on the latest dividend payments. These companies included: ARM, BAE Systems, BG Group, Capita, Fresnillo, Petrofac, Resolution, Smith & Nephew, Tullow Oil and Wood Group.Iconic British luxury brand Burberry gained after reporting a 9.0% rise in underlying revenue in the second half as strong growth in Retail continued to offset a weaker performance in Wholesale.BHP Billiton, one of the world's largest miners, fell despite confirming that it was on track to hit full-year targets despite a lacklustre quarter.Tesco was also lower after posting its first decline in annual profits in two decades. The supermarket giant reported an underlying pre-tax profit of £3.5bn in the year to February 23rd 2013, a 10.7% fall from the £3.92bn the previous year.Financial services group Hargreaves Lansdown was making gains after saying that assets under administration reached record levels in the last three months as investor confidence continues to improve.FTSE 250: Hikma goes ex-div, decides not to sell injectablesHikma Pharmaceuticals was a heavy faller today after going ex-dividend, along with others including Chemring, Rentokil, Taylor Wimpey and Spirax-Sarco Engineering. Hikma also announced that it has decided not to sell its global injectables business despite significant interest.Hochschild Mining fell after reporting a fall in silver production and sales for the first quarter. Silver production came to 4.3m ounces in the three months to March 31st, down from 4.77m in the previous quarter and 4.76m a year earlier. Petra Diamond was heading the other way after discovering a 25.5 carat blue diamond at the Cullinan mine in South Africa. The rare stone is considered to be a high quality gem diamond of top colour. FTSE 100 - RisersBurberry Group (BRBY) 1,320.00p +4.27%Hargreaves Lansdown (HL.) 936.50p +4.06%ARM Holdings (ARM) 890.50p +2.59%Carnival (CCL) 2,291.00p +1.73%Centrica (CNA) 381.40p +1.36%Severn Trent (SVT) 1,759.00p +1.21%International Consolidated Airlines Group SA (CDI) (IAG) 252.40p +1.16%Diageo (DGE) 1,983.00p +1.15%Rolls-Royce Holdings (RR.) 1,127.00p +1.08%BT Group (BT.A) 277.20p +1.02%FTSE 100 - FallersFresnillo (FRES) 1,088.00p -6.29%Resolution Ltd. (RSL) 258.70p -6.27%Evraz (EVR) 157.30p -5.18%BAE Systems (BA.) 375.60p -3.72%Polymetal International (POLY) 719.50p -3.29%Petrofac Ltd. (PFC) 1,297.00p -3.21%Tesco (TSCO) 372.50p -3.21%BG Group (BG.) 1,047.00p -2.97%Prudential (PRU) 1,026.00p -2.56%Weir Group (WEIR) 2,158.00p -2.53%FTSE 250 - RisersSpirent Communications (SPT) 126.90p +3.34%Savills (SVS) 525.50p +2.64%Laird (LRD) 212.60p +2.46%Marston's (MARS) 135.30p +2.19%Synthomer (SYNT) 182.60p +2.18%St James's Place (STJ) 494.40p +1.79%Domino's Pizza Group (DOM) 622.50p +1.72%Rank Group (RNK) 157.60p +1.68%Hiscox Ltd. (HSX) 548.00p +1.67%Premier Farnell (PFL) 205.00p +1.49%FTSE 250 - FallersFerrexpo (FXPO) 163.50p -5.82%Hikma Pharmaceuticals (HIK) 935.00p -5.08%Perform Group (PER) 473.50p -4.61%SVG Capital (SVI) 369.40p -4.50%Lonmin (LMI) 263.10p -4.22%Beazley (BEZ) 204.80p -3.67%Kazakhmys (KAZ) 333.90p -3.41%BlackRock World Mining Trust (BRWM) 489.00p -2.88%SDL (SDL) 408.00p -2.83%Mondi (MNDI) 837.00p -2.73%BC
More News
24 Feb 2022 10:31

TOP NEWS: Hikma Pharmaceutical records revenue growth and lifts payout

(Alliance News) - Hikma Pharmaceutical PLC on Thursday reported full-year revenue growth on a "strong" performance by its three business segments and lifted its shareholder payout.

Read more
24 Feb 2022 07:58

Hikma Pharmaceutical delivers year of 'solid growth' and 'strategic momentum'

(Sharecast News) - Drugmaker Hikma Pharmaceutical said on Thursday that it had delivered another successful year of "solid growth and continued strategic momentum", with both revenue and operating profits improving year-on-year.

Read more
24 Feb 2022 07:50

LONDON MARKET PRE-OPEN: Share buybacks for Lloyds Banking and Hikma

(Alliance News) - Stock prices in London are seen opening sharply lower, with the FTSE 100 called down almost 200 points, amid fear of a full-scale war in eastern Europe after Russia announced the beginning of a military operation in Ukraine.

Read more
17 Feb 2022 16:08

UK earnings, trading statements calendar - next 7 days

Friday 18 February  
NatWest Group PLCFull Year Results
Pod Point Group Holdings PLCFull Year Results
Segro PLCFull Year Results
TBC Bank Group PLCFull Year Results
Monday 21 February 
Bank of Cyprus Holdings PLCFull Year Results
Dechra Pharmaceuticals PLCHalf Year Results
Finsbury Food Group PLCHalf Year Results
Sylvania Platinum LtdHalf Year Results
Tristel PLCTrading Statement
Wilmington PLCHalf Year Results
Tuesday 22 February 
Antofagasta PLCFull Year Results
Bank of Georgia Group PLCFull Year Results
Benchmark Holdings PLCQ1 Results
Blancco Technology Group PLCHalf Year Results
Bluefield Solar Income Fund LtdHalf Year Results
Coca-Cola HBC AGFull Year Results
Hargreaves Lansdown PLCHalf Year Results
HSBC Holdings PLCFull Year Results (at 0400 GMT)
InterContinental Hotels Group PLCFull Year Results
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Smith & Nephew PLCFull Year Results
Springfield Properties PLCHalf Year Results
Synectics PLCFull Year Results
Transense Technologies PLCHalf Year Results
Wednesday 23 February 
Aston Martin Lagonda Global Holdings PLCFull Year Results
Barclays PLCFull Year Results
Capital & Counties Properties PLCFull Year Results
CAP-XX LtdHalf Year Results
Georgia Capital PLCFull Year Results
International Personal Finance PLCFull Year Results
Irish Residential Properties REIT PLCFull Year Results
Metro Bank PLCFull Year Results
Hochschild Mining PLCFull Year Results
Photo-Me International PLCFull Year Results
Rio Tinto PLCFull Year Results
Seraphim Space Investment Trust PLCHalf Year Results
Ted Baker PLCTrading Statement
Unite Group PLCFull Year Results
Thursday 24 February 
Anglo American PLCFull Year Results
BAE Systems PLCFull Year Results
Centrica PLCFull Year Results
Conduit Holdings LtdFull Year Results
Derwent London PLCFull Year Results
Drax Group PLCFull Year Results
Genus PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Howden Joinery Group PLCFull Year Results
Inchcape PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
Macfarlane Group PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Rathbone Group PLCFull Year Results
Ricardo PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
Serco Group PLCFull Year Results
Spectris PLCFull Year Results
St James's Place PLCFull Year Results
Tremor International LtdFull Year Results
WPP PLCFull Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
9 Feb 2022 09:48

LONDON BROKER RATINGS: Barclays downgrades Chemring and boohoo

LONDON BROKER RATINGS: Barclays downgrades Chemring and boohoo

Read more
3 Feb 2022 09:12

Hikma completes acquisition of Teligent's Canadian assets

Hikma completes acquisition of Teligent's Canadian assets

Read more
17 Jan 2022 09:01

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 09:00

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 07:49

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

Read more
17 Jan 2022 07:08

Hikma buys Teligent Canadian assets for $47.75m

(Sharecast News) - Hikma Pharmaceuticals on Monday said it had agreed to buy the Canadian assets of Teligent for $45.75m after the US firm filed for Chapter 11 bankruptcy last year.

Read more
10 Jan 2022 07:44

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

Read more
10 Jan 2022 07:24

Hikma launches new US injectables unit

(Sharecast News) - Hikma Pharmaceuticals on Monday said it was expanding its injectables business with the launch of a new outsourced sterile compounding business in the US.

Read more
21 Dec 2021 15:55

Arecor flags milestone payment from Hikma in first half of next year

(Sharecast News) - Biopharmaceutical company Arecor Therapeutics updated the market on its ongoing exclusive agreement with Hikma Pharmaceuticals to co-develop a new, ready-to-use injectable medicine on Tuesday.

Read more
9 Dec 2021 09:25

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Read more
9 Dec 2021 08:32

Hikma strikes exclusive license agreement with Richter for denosumab

(Sharecast News) - Drugmaker Hikma Pharmaceuticals has entered into an exclusive license agreement with Gedeon Richter to commercialise the latter's denosumab products in the US.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.